Human norepinephrine transporter. Biosynthetic studies using a site-directed polyclonal antibody

Area of Science:

• Neuroscience
• Molecular Biology
• Biochemistry

Background:

• The human norepinephrine transporter (hNET) is a key target for antidepressants and cocaine.
• Understanding hNET's structure and function is vital for developing new therapeutics.
• Specific antibodies are needed to study hNET's biosynthesis and localization.

Purpose of the Study:

• To generate and characterize a novel antibody (N430) against the hNET.
• To investigate the role of glycosylation in hNET maturation, stability, and functional expression.
• To evaluate hNET's biosynthetic pathway using the N430 antibody.

Main Methods:

• Antibodies were raised against synthetic peptides of hNET.
• Indirect immunofluorescence and immunoblotting were used to detect hNET.
• Pulse-chase immunoprecipitation and PNGase F digestion analyzed hNET processing.
• Pharmacological assays assessed norepinephrine transport and antagonist binding.

Main Results:

• The N430 antibody specifically detected hNET in transfected cells.
• Two hNET species (54 kDa and 80 kDa) were identified, with 54 kDa being a transient intermediate.
• N-linked glycosylation was found to be essential for hNET maturation, stability, and membrane expression.
• Inhibition of glycosylation significantly reduced NE transport activity and hNET density.

Conclusions:

• The N430 antibody is a valuable tool for studying hNET.
• N-linked glycosylation plays a critical role in the functional expression of hNET.
• This study provides direct evidence for the biosynthetic steps involved in functional catecholamine transporter expression.